I have just completed Deep Longevity’s Introduction to Longevity Medicine for Physicians. I am not a physician – and that is precisely why I wanted to take it.
Longevity is increasingly discussed as a market: new technologies, diagnostics, clinics and investment opportunities. As someone developing and promoting senior care, I need to understand more than the commercial promise.
I wanted to approach the subject through the questions asked by scientists, physicians and the people whose lives are ultimately affected: what can we measure, what can we prevent, what can research realistically change, and where does uncertainty remain?
Researchers, clinicians, care teams, operators, investors and older adults do not always use the same language. Better decisions become possible when we understand what each perspective contributes – and where its limits lie.
A special thank you to Prof. Evelyne Bischof for pointing me towards this course, which she co-authored, and for helping make this emerging field more accessible.
For me, longevity only matters if it improves the years lived, not simply the years counted.